Structure

Cordycepin

CAS
73-03-0
Catalog Number
ACM73030-1
Category
Inhibitors
Molecular Weight
251.24
Molecular Formula
C10H13N5O3

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Description
Cordycepin (3'-Deoxyadenosine) is a nucleoside derivative and inhibits IL-1β-induced MMP-1 and MMP-3 expression in rheumatoid arthritis synovial fibroblasts (RASFs) in a dose-dependent manner. Cordycepin kills Mycobacterium tuberculosis through hijacking the bacterial adenosine kinase.
Synonyms
3’-Deoxy-adenosin
IUPAC Name
(2R,3R,5S)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolan-3-ol
Canonical SMILES
C1[C@H](O[C@H]([C@@H]1O)N2C=NC3=C(N=CN=C32)N)CO
InChI
InChI=1S/C10H13N5O3/c11-8-7-9(13-3-12-8)15(4-14-7)10-6(17)1-5(2-16)18-10/h3-6,10,16-17H,1-2H2,(H2,11,12,13)/t5-,6+,10+/m0/s1
InChI Key
OFEZSBMBBKLLBJ-BAJZRUMYSA-N
Boiling Point
394.4 °C
Melting Point
225-229 °C
Density
1.29 g/ml
Appearance
Powder

Upstream Synthesis Route 1

  • 161001-78-1
  • 100-27-6
  • 73-03-0

Reference: [1] Helvetica Chimica Acta, 1994, vol. 77, # 5, p. 1267 - 1280

Upstream Synthesis Route 2

  • 51763-58-7
  • 73-03-0

Reference: [1]Synthesis,1985,vol. NO. 12,p. 1108 - 1111

Downstream Synthesis Route 1

  • 63-89-8
  • 73-03-0
  • 116595-57-4

Reference: [1]Shuto; Itoh; Ueda; Imamura; Fukukawa; Tsujino; Matsuda; Ueda
[Chemical and Pharmaceutical Bulletin, 1988, vol. 36, # 1, p. 209 - 217]

Downstream Synthesis Route 2

  • 73-03-0
  • 76-83-5
  • 90813-62-0

Reference: [1]Journal of Medicinal Chemistry,1987,vol. 30,p. 2131 - 2137
[2]Tetrahedron,1984,vol. 40,p. 125 - 135

* For details of the synthesis route, please refer to the original source to ensure accuracy.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.